pPACK-SPIKE™ P1 Variant Spike Protein Lentivector Packaging Mix

Share post on social media:
pPACK-SPIKE™ P1 Variant Spike Protein Lentivector Packaging Mix

Study the spike protein from SARS-CoV-2 Variant P1, a CDC variant of concern, with this packaging mix for lentivirus pseudotyped with the P1 spike protein

  • Based on SBI’s popular and highly cited pPACKH1 Packaging System
  • Uses codon-optimized SARS-CoV-2 “S” protein from variant P1 in place of VSV-G envelope protein
  • Spike protein mutations are L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I, V1176F
  • Ideal for vaccine and antiviral efficacy studies under BSL2 conditions
  • Package any 3rd-generation lentivector reporter of your choice, including SBI’s popular LentiLabeler reporters
Cat. No. Description Size
CVD19-630A-1 pPACK-SPIKE P1, SARS-CoV-2 “S” Pseudotype – P1 Variant – Lentivector Packaging Mix 10 reactions
CVD19-635A-1 pPACK-SPIKE P1, SARS-CoV-2 “S” Pseudotype – P1 Variant – Lentivector Packaging Mix 25 reactions
CVD19-639A-KIT pPACK-SPIKE P1 Combo Kit, includes Cat# CVD19-630A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution (Cat# LV810A-1) 1 kit

How It Works
pPACK-SPIKE is easy to use—simply co-transfect the pPACK-SPIKE Plasmids and your lentivector construct into 293TN producer cells or other lentiviral production cells, isolate pseudoviral particles with an optional concentration step, and conduct your studies.

 

You might also like...

View blog
pPACK-SPIKE™ N501Y, SARS-CoV-2 “S” Pseudotype – N501Y Mutant – Lentivector Packaging Mix
1 min read
pPACK-SPIKE™ N501Y, SARS-CoV-2 “S” Pseudotype – N501Y Mutant – Lentivector Packaging Mix
Stay on top of emerging SARS-CoV-2 variant with new pPACK-SPIKE™
1 min read
Stay on top of emerging SARS-CoV-2 variant with new pPACK-SPIKE™
SBI is proud to announce the newest addition to their growing family of COVID-19 research tools, pPACK-SPIKE B.1.351 RBD Mutations...
Two new options for expressing SARS-CoV-2 Proteins
2 min read
Two new options for expressing SARS-CoV-2 Proteins